|
|
Article: Bradley Pharmaceuticals Anticipates Significant Sales Increases for Lubrin Vaginal Moisturizer as a Result of the Popularity of Viagra.
- Article from:
- Business Wire
- Article date:
- May 7, 1998
CopyrightCOPYRIGHT 1998 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
FAIRFIELD, N.J.--(BUSINESS WIRE)--May 7, 1998--BRADLEY PHARMACEUTICALS, INC. (NASDAQ NM: BPRX) foresees male Viagra(R) (Registered trademark of Pfizer, Inc. NYSE: PFE) patients increased sexual drive significantly affecting female usage of Lubrin(R) Vaginal Lubricant inserts. It is estimated in excess of 20 million post-menopausal women currently suffer from vaginal dryness.
Many health-care experts share the view of Karin Martin, Sex Therapist at Hillside Hospital's Sexuality Center in Lake Success, New York, who spoke about male patients in their mid 40's through 60's taking Viagra(R) and "their partners are happy they are able to have a more complete ...
Related newspaper, magazine, and journal articles:
|
|
Article: Bradley Pharmaceuticals Reminds Stockholders of ...
PR Newswire;
November 14, 2006 ;
700+ words
... ... PRNewswire-FirstCall/ -- BRADLEY PHARMACEUTICALS, INC. , reminds stockholders ... 30 days. Please visit Bradley Pharmaceuticals web site at: http://www.bradpharm.com/ Bradley Pharmaceuticals common stock is listed ...
|
|